We are live on ! Find out more
DCM

DAFNA Capital Management Portfolio holdings

AUM $440M
1-Year Est. Return 109.12%
This Fund
S&P 500
This Quarter Est. Return
+13.31%
1 Year Est. Return
+109.12%
3 Year Est. Return
+239.59%
5 Year Est. Return
+227.89%
10 Year Est. Return
+3,611.91%
AUM
$118M
AUM Growth
+$4.41M
Cap. Flow
-$8.19M
Cap. Flow %
-6.92%
Top 10 Hldgs %
44.84%
Holding
84
New
17
Increased
12
Reduced
22
Closed
11

Top Buys

Rank Stock Value
1
LOXO
Loxo Oncology, Inc
LOXO
+$6.63M
2
BCRX icon
BioCryst Pharmaceuticals
BCRX
+$3.31M
3
CLLS
Cellectis
CLLS
+$1.61M
4
RIGL icon
Rigel Pharmaceuticals
RIGL
+$1.21M
5
BLRX
BioLineRX
BLRX
+$1.07M

Top Sells

Rank Stock Value
1
CYTK icon
Cytokinetics
CYTK
+$2.56M
2
AERI
Aerie Pharmaceuticals
AERI
+$2.3M
3
DERM
Dermira, Inc.
DERM
+$2.28M
4
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
+$2.21M
5
TSRO
TESARO, Inc.
TSRO
+$2.08M

Sector Composition

Rank Sector Weight
1 Healthcare 85.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CHEKW
76
DELISTED
Check-Cap Ltd. Series A Warrant
CHEKW
– –
-15,250
Closed -$10K
SGYP
77
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
– –
-34,000
Closed -$207K
TSRO
78
DELISTED
TESARO, Inc.
TSRO
– –
-15,500
Closed -$2.08M
DSCI
79
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
– –
-353,718
Closed -$1.84M
GNVC
80
DELISTED
GenVec, Inc.
GNVC
– –
-9,580
Closed -$31K
1 2 3
4

Similar funds

CDMG
Creek Drive Management Group San Francisco, California $439M AUM
STCG
Speece Thorson Capital Group Minnetonka, Minnesota $439M AUM 10.15% 1-Year Est. Return
SCP
SailingStone Capital Partners Houston, Texas $440M AUM 127.21% 1-Year Est. Return
CAAM
Cape Ann Asset Management London, United Kingdom $440M AUM 96.23% 1-Year Est. Return
HCM
Harvey Capital Management Palm Beach, Florida $439M AUM 37.68% 1-Year Est. Return
CPW
Cove Private Wealth Oyster Bay Cove, New York $440M AUM 27.56% 1-Year Est. Return
BOA
Birnam Oak Advisors New York $441M AUM 37.12% 1-Year Est. Return
DWML
Decker Wealth Management LLC Nashville, Tennessee $441M AUM

DAFNA Capital Management's Q1 2017 Portfolio in Review

As of Q1 2017, DAFNA Capital Management held 84 positions worth $118M, up 3.9% from $114M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

DAFNA Capital Management withdrew a net $8.19M in Q1 2017, closing 11 positions and reducing 22 holdings. Its most notable exit was Cytokinetics, an estimated $2.56M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 86% of assets, up from 82% a quarter earlier.

Against the trend, DAFNA Capital Management opened a new position in Cellectis worth $1.83M.

  • DAFNA Capital Management's largest Q1 2017 buy was Cellectis: 76,404 shares worth $1.83M.
  • DAFNA Capital Management added most to Loxo Oncology, Inc in Q1 2017, an estimated $6.63M increase.
  • DAFNA Capital Management's biggest Q1 2017 reduction was Aerie Pharmaceuticals, cutting an estimated $2.3M.
  • DAFNA Capital Management fully exited Cytokinetics in Q1 2017, selling an estimated $2.56M.
  • DAFNA Capital Management's ten largest holdings make up 45% of its $118M portfolio in Q1 2017.
  • DAFNA Capital Management opened 17 new positions and closed 11 in Q1 2017.
  • DAFNA Capital Management's portfolio value rose 3.9% quarter-over-quarter to $118M.

Based on DAFNA Capital Management's 13F filing for Q1 2017, filed 15 May 2017.